Abstract
On August 15, 2005, the Food and Drug Administration (FDA) and the Association of American Medical Colleges released a joint report that examines possible steps to accelerate drug discovery and development. The report, entitled Drug Development Science: Obstacles and Opportunities for Collaboration Among Academia, Industry and Government, is the product of a two-day conference among leaders from the pharmaceutical industry, academia, and FDA. The goal of the conference and the report was to explore means of overcoming the high failure rate for tentative drug candidates.
Disciplines
Antitrust and Trade Regulation
Date of this Version
January 2006
Recommended Citation
Mark Heller, Hollie Baker, Robert Barry, James Burling, and Suyong Kim, "PHARMABULLETIN Issue 3, Fall 2005" (January 2006). Wilmer Cutler Pickering Hale and Dorr Antitrust Series. Working Paper 7.
https://law.bepress.com/wilmer/art7